Iain B. McInnes

105.4k total citations · 35 hit papers
738 papers, 58.4k citations indexed

About

Iain B. McInnes is a scholar working on Rheumatology, Immunology and Hematology. According to data from OpenAlex, Iain B. McInnes has authored 738 papers receiving a total of 58.4k indexed citations (citations by other indexed papers that have themselves been cited), including 433 papers in Rheumatology, 358 papers in Immunology and 245 papers in Hematology. Recurrent topics in Iain B. McInnes's work include Rheumatoid Arthritis Research and Therapies (302 papers), Autoimmune and Inflammatory Disorders Research (234 papers) and Spondyloarthritis Studies and Treatments (202 papers). Iain B. McInnes is often cited by papers focused on Rheumatoid Arthritis Research and Therapies (302 papers), Autoimmune and Inflammatory Disorders Research (234 papers) and Spondyloarthritis Studies and Treatments (202 papers). Iain B. McInnes collaborates with scholars based in United Kingdom, United States and Canada. Iain B. McInnes's co-authors include Georg Schett, Foo Y. Liew, Daniel Aletaha, Josef S Smolen, Naveed Sattar, Bernard P. Leung, Gary S. Firestein, Stefan Siebert, J. Alastair Gracie and Fionula M. Brennan and has published in prestigious journals such as New England Journal of Medicine, Proceedings of the National Academy of Sciences and The Lancet.

In The Last Decade

Iain B. McInnes

722 papers receiving 57.3k citations

Hit Papers

The Pathogenesis of Rheumatoid Arthritis 1999 2026 2008 2017 2011 2016 2007 2018 2015 1000 2.0k 3.0k 4.0k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. The Pathogenesis of Rheumatoid Arthritis
    2011 4.1k citations Iain B. McInnes, Georg Schett profile →
  2. Rheumatoid arthritis
    2016 3.4k citations Iain B. McInnes et al. profile →
  3. Cytokines in the pathogenesis of rheumatoid arthritis
    2007 2.0k citations Iain B. McInnes, Georg Schett profile →
  4. Rheumatoid arthritis
    2018 1.7k citations Gerd R Burmester, Paul Emery et al. profile →
  5. The JAK-STAT Pathway: Impact on Human Disease and Therapeutic Intervention
    2015 1.1k citations Iain B. McInnes et al. profile →
  6. Pathogenetic insights from the treatment of rheumatoid arthritis
    2017 997 citations Iain B. McInnes, Georg Schett profile →
  7. EULAR evidence-based recommendations for cardiovascular risk management in patients with rheumatoid arthritis and other forms of inflammatory arthritis
    2009 969 citations Iain B. McInnes, Naveed Sattar et al. Annals of the Rheumatic Diseases profile →
  8. Evidence that cytokines play a role in rheumatoid arthritis
    2008 902 citations Iain B. McInnes et al. profile →
  9. Immunopathogenesis of Rheumatoid Arthritis
    2017 849 citations Iain B. McInnes et al. profile →
  10. Disease-associated functions of IL-33: the new kid in the IL-1 family
    2010 831 citations Foo Y. Liew, Nick Pitman et al. profile →
  11. Explaining How “High-Grade” Systemic Inflammation Accelerates Vascular Risk in Rheumatoid Arthritis
    2003 707 citations Naveed Sattar, Iain B. McInnes et al. profile →
  12. Secukinumab, a human anti-interleukin-17A monoclonal antibody, in patients with psoriatic arthritis (FUTURE 2): a randomised, double-blind, placebo-controlled, phase 3 trial
    2015 650 citations Iain B. McInnes, Philip J. Mease et al. profile →
  13. Trial of Atorvastatin in Rheumatoid Arthritis (TARA): double-blind, randomised placebo-controlled trial
    2004 612 citations Iain B. McInnes, Ian Ford et al. profile →
  14. Efficacy and safety of ustekinumab in patients with active psoriatic arthritis: 1 year results of the phase 3, multicentre, double-blind, placebo-controlled PSUMMIT 1 trial
    2013 606 citations Iain B. McInnes, Alice B. Gottlieb et al. profile →
  15. IL-33 Amplifies the Polarization of Alternatively Activated Macrophages That Contribute to Airway Inflammation
    2009 579 citations Mariola Kurowska‐Stolarska, Peter Kewin et al. The Journal of Immunology profile →
  16. Secukinumab Inhibition of Interleukin-17A in Patients with Psoriatic Arthritis
    2015 572 citations Philip J. Mease, Iain B. McInnes et al. profile →
  17. IL-33 reduces the development of atherosclerosis
    2008 543 citations Ashley M. Miller, Damo Xu et al. profile →
  18. A proinflammatory role for IL-18 in rheumatoid arthritis
    1999 537 citations Bernard P. Leung, Xiaoqing Wei et al. profile →
  19. Interleukin-18
    2003 524 citations Iain B. McInnes et al. profile →
  20. Efficacy and safety of the anti-IL-12/23 p40 monoclonal antibody, ustekinumab, in patients with active psoriatic arthritis despite conventional non-biological and biological anti-tumour necrosis factor therapy: 6-month and 1-year results of the phase 3, multicentre, double-blind, placebo-controlled, randomised PSUMMIT 2 trial
    2014 508 citations Christopher T. Ritchlin, Proton Rahman et al. Annals of the Rheumatic Diseases profile →
  21. MicroRNA-155 as a proinflammatory regulator in clinical and experimental arthritis
    2011 503 citations Mariola Kurowska‐Stolarska, Darren L. Asquith et al. Proceedings of the National Academy of Sciences profile →
  22. Obesity Is a Risk Factor for Severe COVID-19 Infection
    2020 479 citations Naveed Sattar, Iain B. McInnes et al. profile →
  23. Tendinopathy
    2021 473 citations Iain B. McInnes et al. profile →
  24. Golimumab, a new human tumor necrosis factor α antibody, administered every four weeks as a subcutaneous injection in psoriatic arthritis: Twenty‐four–week efficacy and safety results of a randomized, placebo‐controlled study
    2009 462 citations Arthur Kavanaugh, Iain B. McInnes et al. Arthritis & Rheumatism profile →
  25. Cytokines in rheumatoid arthritis — shaping the immunological landscape
    2015 395 citations Iain B. McInnes et al. Nature Reviews Rheumatology profile →
  26. Incidence, prevalence, and co-occurrence of autoimmune disorders over time and by age, sex, and socioeconomic status: a population-based cohort study of 22 million individuals in the UK
    2023 381 citations Naveed Sattar, Iain B. McInnes et al. profile →
  27. Inflammatory mechanisms in tendinopathy – towards translation
    2017 291 citations Iain B. McInnes et al. Nature Reviews Rheumatology profile →
  28. Cytokines as Therapeutic Targets in Rheumatoid Arthritis and Other Inflammatory Diseases
    2015 268 citations Stefan Siebert, Iain B. McInnes et al. profile →
  29. Guselkumab in biologic-naive patients with active psoriatic arthritis (DISCOVER-2): a double-blind, randomised, placebo-controlled phase 3 trial
    2020 242 citations Philip J. Mease, Proton Rahman et al. profile →
  30. The pathogenesis of rheumatoid arthritis
    2022 229 citations Iain B. McInnes et al. profile →
  31. Reframing Immune-Mediated Inflammatory Diseases through Signature Cytokine Hubs
    2021 213 citations Georg Schett, Iain B. McInnes et al. profile →
  32. Safety of synthetic and biological DMARDs: a systematic literature review informing the 2019 update of the EULAR recommendations for the management of rheumatoid arthritis
    2020 195 citations Ronald van Vollenhoven, Iain B. McInnes et al. Annals of the Rheumatic Diseases profile →
  33. Trial of Upadacitinib and Adalimumab for Psoriatic Arthritis
    2021 182 citations Iain B. McInnes, Frank Behrens et al. profile →
  34. Immune-mediated inflammatory disease therapeutics: past, present and future
    2021 179 citations Iain B. McInnes et al. profile →
  35. IL-23 past, present, and future: a roadmap to advancing IL-23 science and therapy
    2024 42 citations Christopher T. Ritchlin, Iain B. McInnes et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Iain B. McInnes United Kingdom 112 25.5k 24.4k 12.2k 10.3k 6.8k 738 58.4k
Georg Schett Germany 118 18.0k 0.7× 22.5k 0.9× 21.6k 1.8× 6.1k 0.6× 8.7k 1.3× 1.1k 59.6k
T. Huizinga Netherlands 113 14.7k 0.6× 28.4k 1.2× 6.6k 0.5× 6.9k 0.7× 4.4k 0.6× 1.1k 49.4k
Marc Feldmann United Kingdom 114 23.9k 0.9× 15.6k 0.6× 11.3k 0.9× 5.5k 0.5× 8.0k 1.2× 556 53.8k
Peter E. Lipsky United States 107 23.2k 0.9× 13.8k 0.6× 8.4k 0.7× 4.6k 0.4× 5.3k 0.8× 661 46.7k
Paul Emery United Kingdom 123 18.2k 0.7× 45.9k 1.9× 5.8k 0.5× 17.3k 1.7× 5.0k 0.7× 1.0k 67.0k
Yehuda Shoenfeld Israel 115 20.2k 0.8× 23.0k 0.9× 8.2k 0.7× 8.3k 0.8× 3.0k 0.4× 1.6k 63.1k
Lars Klareskog Sweden 109 13.8k 0.5× 22.1k 0.9× 6.1k 0.5× 5.1k 0.5× 4.3k 0.6× 657 42.3k
Paul P. Tak Netherlands 96 11.8k 0.5× 14.0k 0.6× 8.6k 0.7× 4.4k 0.4× 4.5k 0.7× 459 33.5k
David Isenberg United Kingdom 102 22.8k 0.9× 27.9k 1.1× 6.0k 0.5× 4.5k 0.4× 3.1k 0.4× 969 45.8k
Tadamitsu Kishimoto Japan 145 34.0k 1.3× 8.2k 0.3× 22.3k 1.8× 8.8k 0.9× 25.7k 3.8× 643 77.6k

Countries citing papers authored by Iain B. McInnes

Since Specialization
Citations

This map shows the geographic impact of Iain B. McInnes's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Iain B. McInnes with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Iain B. McInnes more than expected).

Fields of papers citing papers by Iain B. McInnes

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Iain B. McInnes. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Iain B. McInnes. The network helps show where Iain B. McInnes may publish in the future.

Co-authorship network of co-authors of Iain B. McInnes

This figure shows the co-authorship network connecting the top 25 collaborators of Iain B. McInnes. A scholar is included among the top collaborators of Iain B. McInnes based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Iain B. McInnes. Iain B. McInnes is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Charles‐Schoeman, Christina, Jon T. Giles, Nancy E. Lane, et al.. (2024). Impact of Upadacitinib on Laboratory Parameters and Related Adverse Events in Patients with RA: Integrated Data Up to 6.5 Years. Rheumatology and Therapy. 11(1). 157–175. 5 indexed citations
2.
Joy, Mark, et al.. (2024). Defining and Risk-Stratifying Immunosuppression (the DESTINIES Study): Protocol for an Electronic Delphi Study. JMIR Research Protocols. 13. e56271–e56271. 1 indexed citations
3.
Huesa, Carmen, Sabarinadh Chilaka, James Doonan, et al.. (2023). IĸB Protein BCL3 as a Controller of Osteogenesis and Bone Health. Arthritis & Rheumatology. 75(12). 2148–2160. 3 indexed citations
4.
5.
Brock, James B., Neil Basu, Johannes C. M. Schlachetzki, et al.. (2023). Immune mechanisms of depression in rheumatoid arthritis. Nature Reviews Rheumatology. 19(12). 790–804. 41 indexed citations
6.
7.
Schett, Georg, Proton Rahman, Christopher T. Ritchlin, et al.. (2022). Psoriatic arthritis from a mechanistic perspective. Nature Reviews Rheumatology. 18(6). 311–325. 89 indexed citations
8.
Mease, Philip J., Iain B. McInnes, Lai‐Shan Tam, et al.. (2021). Comparative effectiveness of guselkumab in psoriatic arthritis: results from systematic literature review and network meta-analysis. Lara D. Veeken. 60(5). 2109–2121. 42 indexed citations
9.
Sweet, Kristen, Qingxuan Song, Matthew J. Loza, et al.. (2021). Guselkumab induces robust reduction in acute phase proteins and type 17 effector cytokines in active psoriatic arthritis: results from phase 3 trials. RMD Open. 7(2). e001679–e001679. 32 indexed citations
10.
Orbai, Ana‐Maria, Iain B. McInnes, Laura C. Coates, et al.. (2019). Effect of Secukinumab on the Different GRAPPA-OMERACT Core Domains in Psoriatic Arthritis: A Pooled Analysis of 2049 Patients. The Journal of Rheumatology. 47(6). 854–864. 13 indexed citations
11.
Burmester, Gerd R, Iain B. McInnes, Joel M. Kremer, et al.. (2018). Mavrilimumab, a Fully Human Granulocyte–Macrophage Colony‐Stimulating Factor Receptor α Monoclonal Antibody. Arthritis & Rheumatology. 70(5). 679–689. 62 indexed citations
12.
Weinblatt, Michael E., Iain B. McInnes, Joel M. Kremer, et al.. (2017). A Randomized Phase II b Study of Mavrilimumab and Golimumab in Rheumatoid Arthritis. Arthritis & Rheumatology. 70(1). 49–59. 72 indexed citations
13.
Gottlieb, Alice B., Philip Mease, Iain B. McInnes, et al.. (2014). Secukinumab, a Human Anti-Interleukin-17A Monoclonal Antibody, Significantly Reduces Psoriasis Burden in Patients with Psoriatic Arthritis: Results from a Phase 3 Randomized Controlled Trial. Queensland's institutional digital repository (The University of Queensland). 66. 12 indexed citations
14.
Miller, Ashley M., David Purves, Alex McConnachie, et al.. (2012). Soluble ST2 Associates with Diabetes but Not Established Cardiovascular Risk Factors: A New Inflammatory Pathway of Relevance to Diabetes?. PLoS ONE. 7(10). e47830–e47830. 56 indexed citations
15.
Kavanaugh, Arthur, D. van der Heijde, D. Gladman, et al.. (2010). GOLIMUMAB INHIBITS PROGRESSION OF RADIOGRAPHIC DAMAGE IN PATIENTS WITH PSORIATIC ARTHRITIS: 52 WEEK RESULTS FROM THE GO-REVEAL STUDY. Lara D. Veeken. 50. 143–143. 9 indexed citations
16.
Asquith, Darren L., Ashley M. Miller, Axel J. Hueber, et al.. (2010). Apolipoprotein E–deficient mice are resistant to the development of collagen‐induced arthritis. Arthritis & Rheumatism. 62(2). 472–477. 14 indexed citations
17.
Xu, Damo, Hui‐Rong Jiang, Peter Kewin, et al.. (2008). IL-33 exacerbates antigen-induced arthritis by activating mast cells. Proceedings of the National Academy of Sciences. 105(31). 10913–10918. 396 indexed citations
18.
Emery, Paul, et al.. (2007). Clinical identification and treatment of a rapidly progressing disease state in patients with rheumatoid arthritis. Lara D. Veeken. 47(4). 392–398. 66 indexed citations
19.
McInnes, Iain B., et al.. (1998). Septic Arthritis Following Staphylococcus aureus Infection in Mice Lacking Inducible Nitric Oxide Synthase. The Journal of Immunology. 160(1). 308–315. 82 indexed citations
20.
Williams, Rob, et al.. (1980). Gastroenterological Society of Australia, Annual Scientific Meeting, May 1980. Australian and New Zealand Journal of Medicine. 10(5). 583–595. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Georg Schett Breakdown of academic impact, for papers by T. Huizinga Breakdown of academic impact, for papers by Marc Feldmann Breakdown of academic impact, for papers by Peter E. Lipsky Breakdown of academic impact, for papers by Paul Emery Breakdown of academic impact, for papers by Yehuda Shoenfeld Breakdown of academic impact, for papers by Lars Klareskog Breakdown of academic impact, for papers by Paul P. Tak Breakdown of academic impact, for papers by David Isenberg Breakdown of academic impact, for papers by Tadamitsu Kishimoto
Rankless by CCL
2026